Discussion on the Establishment of Drug Relief Fund in China

[1]

HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia. 535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.

[2]

ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei. Analysis of neuropsychiatric adverse reactions caused by zolpidem [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.

[3]

LYU Tianyi, KUANG Li, CHEN Mingying. Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram [J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.

[4]

XU Shungui. 105 Cases of Adverse Drug Reactions Indcued by Ibuprofen in Our Hosptial [J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 164-167.

[5]

LIU Chen, CHU Yanqi, YAN Suying, JIN Chao, LIU Tong, XING Liqiu, ZHANG Xiao. Analysis of 93 Reports of Adverse Drug Reactions Induced by Edaravone Injection [J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 174-178.

[6]

ZHAO Cui-hong, TAO Yi-xiu, WANG Sheng-hai, ZHAO Qiang, MENG Qing-yong, ZHANG Han-xiang, QING Ming-ying, MA Wen-xia, MI Man. Study on Related Factors of Postoperative Nausea and Vomiting and Clinical Intervention in Patients with Intraspinal Anesthesia [J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 201-204.

[7]

ZHAO Rui, CUI Xiangli, LIU Lihong. Pharmaceutical Care of a Patient with Hydroxychloroquine Induced Long QT Syndrome [J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 690-692.

[8]

WANG Lin, LI Shuang, LI Hua-bin, JU Yong-jing. Analysis of Adverse Drug Reactions about 141 Cases of Dextran 40 and Amino Acids Injection [J]. Chinese Journal of Pharmacovigilance, 2018, 15(1): 45-48.

[9]

JIA Wang-ping, GUO Dai-hong, TIAN Xiao-yan, KOU Wei, WANG Xiao-yu, ZHAO Su-yu, HU Peng-zhou. Analysis of 1110 Cases of Drug-induced Liver Injury in 79 Hospitals [J]. Chinese Journal of Pharmacovigilance, 2017, 14(8): 481-485.

[10]

[11]

FAN Yan, TANG Ren, JING Chun-mei ,LI Xin-ling. Discussion on the Key Points of Article Describing Adverse Drug Reaction Case in Pharmaceutical Journal [J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 99-101.

[12]

ZHUANG Hong-yan, LIU Shan-shan ,GUO Wei, MA Xin, HAO Hong-bing ,ZHANG Yi ,NIU Song. Analysis of 121 Cases of Adverse Drug Reactions in Elderly Patients in Psychiatry [J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 105-108.

[13]

ZHANG Li-jun,SONG Jiao-jiao. Analysis of 372 Cases of Adverse Drug Reactions Induced by Ornidazole Sodium Chloride Injection [J]. Chinese Journal of Pharmacovigilance, 2017, 14(10): 622-625.

[14]

WU Zhao-zhao, LONG Li-ping, CHEN Xi, CHEN Guang-jian. Analysis of 193 Cases of Adverse Drug Reactions Induced by Zhengqingfengtongning Sustained Release Tablets [J]. Chinese Journal of Pharmacovigilance, 2016, 13(8): 489-491.

[15]

LI Ning, REN Jing-tian. Discussion on How Drug Manufacturers Report Individual Case Adverse Drug Reactions [J]. Chinese Journal of Pharmacovigilance, 2016, 13(2): 80-83.

PDF (PC)